info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of vulva

C3_VULVA

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

only females

313377

2. Check conditions

None

313377

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 C51
  • Cause of death: ICD-9 184[1-4]
  • Cause of death: ICD-8 1841
  • Cancer registry: Topography ICD-O-3 C51
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

2 out of 7 registries used, show all original rules.

399

4. Check minimum number of events

None

399

5. Include endpoints

None

399

6. Filter based on genotype QC (FinnGen only)

366

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 366 366 -
Unadjusted period prevalence (%) 0.13 0.13 -
Median age at first event (years) 69.38 69.38 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
377
Matched controls
3770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
109.6
307.7
238
58
ULA02
NOMESCO Finland
Kolposcopy
36.5
292.8
259
214
LFC00
NOMESCO Finland
Partial excision of vulva
1595.0
196.3
174
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
102.9
189.6
99
13
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
+∞
157.7
140
*
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
+∞
146.7
131
*
B01AB10
ATC
tinzaparin; parenteral
14.0
136.2
161
191
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
133.5
120
*
H02AB02
ATC
dexamethasone; systemic
41.6
119.0
74
22
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
+∞
118.1
107
*
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
13.8
100.8
107
105
LEB00
NOMESCO Finland
Biopsy of vagina
27.9
97.7
69
30
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
8.7
90.3
155
281
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
+∞
89.2
82
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
85.8
79
*
JN4AD
NOMESCO Finland
Body CT examination
11.5
84.7
101
116
N76.6
ICD-10 Finland
Ulceration of vulva
38.4
84.1
53
16
XX3DW
NOMESCO Finland
Time consuming IT work
12.9
81.7
88
87
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
+∞
81.2
75
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.3
80.5
62
33
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
+∞
74.5
69
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
7.2
64.1
119
227
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
63.3
59
*
JN4BD
NOMESCO Finland
Extensive body CT
11.8
61.4
68
69
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
13.5
60.0
60
52
ZZR00
NOMESCO Finland
Flap of skin
232.3
58.9
59
*
WZC00
NOMESCO Finland
Treatment plan or consultation
5.2
56.9
205
699
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
56.7
53
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
170.7
56.6
58
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
15.1
52.0
48
36
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
571.3
51.7
50
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
51.2
48
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
50.1
47
*
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
146.9
49.1
51
*
WF002
NOMESCO Finland
Radical radiotherapy
143.6
48.1
50
*
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
+∞
47.9
45
*
D07AD01
ATC
clobetasol; topical
4.8
47.4
154
472
A03FA01
ATC
metoclopramide; systemic, rectal
5.1
46.4
132
363
A04AA01
ATC
ondansetron; systemic, rectal
9.5
46.2
59
72
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
10.3
45.4
54
60
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.8
44.8
98
214
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
15.7
41.3
37
26
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
39.3
37
*
Z51.5
ICD-10 Finland
Palliative care
7.2
39.1
64
104
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.0
38.7
201
843
C51.04
ICD-10 Finland
Basal cell carcinoma of labium majus
+∞
36.0
34
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
34.9
33
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
34.9
33
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
33.9
32
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
356.7
33.4
33
*
D39.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other female genital organs
128.2
33.3
35
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
32.8
31
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
32.8
31
*
C51.1
ICD-10 Finland
Malignant neoplasm: Labium minus
+∞
32.8
31
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
6.6
32.5
57
99
8070/3-C51.1
ICD-O-3
Squamous cell carcinoma, NOS, of labium minus
+∞
31.7
30
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.3
31.4
58
106
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.2
31.1
34
33
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
33.3
30.1
39
13
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
29.6
28
*
LFD00
NOMESCO Finland
Vulvectomy
+∞
29.6
28
*
C51.0
ICD-10 Finland
Malignant neoplasm: Labium majus
+∞
29.6
28
*
HA1AA
NOMESCO Finland
X-ray mammography
6.1
27.5
52
97
130
Kela drug reimbursment
Malignant tumour
+∞
27.4
26
*
8070/3-C51.0
ICD-O-3
Squamous cell carcinoma, NOS, of labium majus
+∞
27.4
26
*
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
28.2
26.7
36
14
115
Kela drug reimbursment
Breast cancer
+∞
26.4
25
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
100.6
26.0
28
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
25.3
24
*
WX402
NOMESCO Finland
General anaesthesia
3.5
25.0
109
390
C51.09
ICD-10 Finland
Malignant tumor of the labium majus, unspecified histology
+∞
24.2
23
*
B01AB05
ATC
enoxaparin; parenteral
3.0
24.0
181
890
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.6
23.3
31
39
8090/3-C51.9
ICD-O-3
Basal cell carcinoma, NOS, of vulva, NOS
+∞
23.2
22
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
22.1
21
*
WZC30
NOMESCO Finland
Teaching
3.7
21.9
80
253
WF004
NOMESCO Finland
Palliative radiotherapy
233.0
21.8
22
*
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
26.0
21.2
29
12
C51.21
ICD-10 Finland
Squamous cell carcinoma of the clitoris
+∞
21.0
20
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
21.0
20
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
221.7
20.8
21
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
20.0
19
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
110.9
19.8
21
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.4
19.4
26
33
N02AA05
ATC
oxycodone; systemic
3.0
19.4
113
473
8542/3-C51.9
ICD-O-3
Paget disease, extramammary of vulva, NOS
+∞
18.9
18
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.7
18.6
36
68
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.3
18.3
51
132
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
34.9
18.2
23
7
X77
ICPC
Malignant neopl genital female other
+∞
17.8
17
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
17.8
17
*
8720/3-C51.9
ICD-O-3
Malignant melanoma, NOS, of vulva, NOS
+∞
17.8
17
*
A04AD12
ATC
aprepitant; systemic
+∞
17.8
17
*
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
+∞
17.8
17
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
188.5
17.7
18
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
188.5
17.7
18
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
16.8
16
*
8090/3-C51.0
ICD-O-3
Basal cell carcinoma, NOS, of labium majus
+∞
16.8
16
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.2
16.7
36
75
ZX090
NOMESCO Finland
Other technic of radiotherapy
94.3
16.7
18
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
177.5
16.6
17
*
L02BG04
ATC
letrozole; oral
31.6
16.3
21
7
N90.0
ICD-10 Finland
Mild vulvar dysplasia
49.8
16.2
19
*
A46
ICD-10 Finland
Erysipelas
2.9
15.9
88
354
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
15.9
52
151
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
15.7
15
*
C51.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of vulva
+∞
15.7
15
*
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
88.9
15.7
17
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.0
15.7
85
338
WX320
NOMESCO Finland
Spinalanesthesy
2.5
15.2
142
740
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
47.1
15.2
18
*
LFE10
NOMESCO Finland
Plastic repair of vulva
47.1
15.2
18
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
47.1
15.2
18
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
14.9
63
216
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
83.4
14.7
16
*
C51.19
ICD-10 Finland
Adenocarcinoma of the labium minus, unspecified histology
+∞
14.7
14
*
C519, 8086, 3
ICD-O-3
+∞
14.7
14
*
A79
ICPC
Malignancy NOS
+∞
14.7
14
*
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
23.4
14.4
20
9
C51.89
ICD-10 Finland
Overall malignant tumor of the vulva, unspecified histology
+∞
13.6
13
*
C51.13
ICD-10 Finland
Melanoma and labium minus
+∞
13.6
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.6
13
*
L03AA13
ATC
pegfilgrastim; parenteral
145.0
13.5
14
*
XX2RW, ,
NOMESCO Finland
41.7
13.3
16
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.3
13.1
27
54
D06BB10
ATC
imiquimod; topical
4.1
13.1
38
101
J01CE08
ATC
benzathine benzylpenicillin; parenteral
14.7
12.9
21
15
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
72.4
12.7
14
*
WZC15, ,
NOMESCO Finland
72.4
12.7
14
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
12.6
12
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
12.6
12
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
12.6
12
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.2
12.1
17
8
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
11.5
11
*
C519, 8085, 3
ICD-O-3
+∞
11.5
11
*
LFE96
NOMESCO Finland
Other repair of vulva or perineum
+∞
11.5
11
*
TJF80
NOMESCO Finland
Ostomy education
61.8
10.7
12
*
D28.0
ICD-10 Finland
Benign neoplasm: Vulva
14.8
10.6
17
12
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
10.5
54
206
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
113.0
10.5
11
*
LFW96
NOMESCO Finland
Other operation on vulva or perineum
113.0
10.5
11
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
10.5
10
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.5
10
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
10.5
10
*
C511, 8086, 3
ICD-O-3
+∞
10.5
10
*
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
+∞
10.5
10
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
33.6
10.4
13
*
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
41.2
10.0
12
*
N90.4
ICD-10 Finland
Leukoplakia of vulva
12.7
9.9
17
14
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
9.9
99
519
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.4
9.8
25
60
P01AB01
ATC
metronidazole; oral, rectal
2.0
9.7
188
1257
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
56.5
9.7
11
*
5702
FHL
Local lymph node removal (eg armpit, groin)
102.5
9.5
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
9.4
9
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
9.4
9
*
C510, 8086, 3
ICD-O-3
+∞
9.4
9
*
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
9.4
9
*
C51.03
ICD-10 Finland
Melanoma and labium majus
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
9.4
9
*
L03AA02
ATC
filgrastim; parenteral
+∞
9.4
9
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
10.4
9.1
17
17
JFF23
NOMESCO Finland
Transversostomy
24.7
9.0
12
5
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.1
8.7
24
61
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
8.7
79
395
X81
ICPC
Genital neopl female other/unspecif
51.2
8.7
10
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
51.2
8.7
10
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
3.2
8.6
35
117
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
7.6
8.6
19
26
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
8.5
60
269
Z51.0
ICD-10 Finland
Radiotherapy session
92.0
8.4
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
8.4
93
504
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
8.4
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.4
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
+∞
8.4
8
*
L01BC06
ATC
capecitabine; oral
+∞
8.4
8
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
8.4
8
*
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
+∞
8.4
8
*
WW500
NOMESCO Finland
Blood transfusion
6.5
8.1
20
32
Z93.3
ICD-10 Finland
Colostomy status
34.1
8.1
10
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
8.1
147
947
LCA06
NOMESCO Finland
Biopsy of endometrium
2.2
8.0
72
358
D05BB02
ATC
acitretin; oral
6.8
8.0
19
29
J01DB01
ATC
cefalexin; oral
2.3
7.9
318
2654
X16
ICPC
Vulval symptom/complaint
6.2
7.8
20
34
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.4
7.7
28
87
E0000UV, ,
ATC
1.8
7.6
182
1272
8477
FHL
Vulvectomy
+∞
7.3
7
*
1844A
ICD-9 Finland
Malignant neoplasm of other and unspecified female genital organs, Vulva, unspecified
+∞
7.3
7
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
C51.84
ICD-10 Finland
Overall basal cell carcinoma of vulva
+∞
7.3
7
*
L02BA01
ATC
tamoxifen; oral
+∞
7.3
7
*
ZXC40
NOMESCO Finland
Use of ultrasound
20.5
7.2
10
5
ZX120
NOMESCO Finland
Intravenous
2.9
7.0
33
120
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.6
7.0
23
67
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
14.1
6.9
11
8
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
14.1
6.9
11
8
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
40.8
6.8
8
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
17.1
6.8
10
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.7
190
1381
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
6.7
59
291
QB4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in groin or genital area (from front)
71.0
6.4
7
*
KDD00
NOMESCO Finland
Partial excision of urethra
71.0
6.4
7
*
L03.3
ICD-10 Finland
Cellulitis of trunk
14.6
6.4
10
7
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.0
6.3
18
47
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
11.3
6.3
11
10
C510, 8085, 3
ICD-O-3
+∞
6.3
6
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
6.3
6
*
HA1SA
NOMESCO Finland
Expansion mammography
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
TQW80
NOMESCO Finland
Local dermatologic skincare
4.2
6.1
16
39
A63.0
ICD-10 Finland
Anogenital (venereal) warts
5.3
6.1
17
33

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
148
71
33.67
207.79
1.8
1.3
—
—
—
0
0
262
1072
5.73
58.41
5.0
1.7
—
—
—
0
0
103
212
6.31
50.53
1.5
1.1
—
—
—
0
0
48
45
12.08
45.31
2.4
1.6
—
—
—
0
0
278
1400
4.75
42.30
4.1
2.3
—
—
estimate
—
0
0
126
365
4.68
40.92
2.5
1.7
—
—
—
0
0
143
493
4.06
36.20
4.0
2.1
0.75
0.82
mmol/l
7.69
136
440
96
250
4.81
35.18
2.4
1.9
0.22
0.20
g/l
2.13
89
235
198
951
3.28
28.54
3.3
2.0
—
—
—
0
0
257
1554
3.05
22.84
6.5
3.6
34.58
35.44
g/l
1.61
244
1442
156
731
2.93
22.22
3.4
1.9
—
—
—
0
0
108
438
3.05
19.62
2.9
1.9
—
—
—
0
0
162
829
2.67
18.82
5.6
3.9
—
—
—
0
0
263
1752
2.66
16.99
13.1
6.3
4.15
4.16
e9/l
0.04
236
1510
140
712
2.54
15.96
1.5
1.3
—
—
—
0
0
250
1657
2.51
15.81
8.3
3.4
9.74
10.44
umol/l
0.99
238
1549
233
1598
2.20
12.17
14.7
17.0
1.19
1.30
inr
2.73
203
1333
211
1439
2.06
10.61
4.6
3.9
—
—
—
0
0
173
1117
2.01
9.93
4.8
3.3
7.40
7.40
ph
0.71
126
810
249
1844
2.03
9.50
8.2
5.6
1.22
1.22
mmol/l
0.80
214
1613
256
1937
2.00
8.91
5.5
4.6
0.00
0.01
estimate
0.69
60
383
226
1643
1.94
8.80
8.0
4.9
1.21
1.22
mmol/l
0.53
210
1488
81
409
2.25
8.75
4.9
3.5
1.04
1.04
mmol/l
0.06
72
359
8
0
+∞
8.36
1.0
0.0
—
—
—
0
0
309
2529
2.23
8.36
11.3
5.5
82.40
76.71
u/l
1.28
293
2344
19
42
4.71
8.21
1.5
1.2
—
—
—
0
0
39
145
2.88
7.95
1.7
1.2
—
—
—
0
0
47
193
2.64
7.95
4.2
1.4
5.52
2.65
ug/l
0.60
34
148
59
271
2.40
7.89
8.3
5.1
—
—
—
0
0
62
299
2.28
7.41
2.1
2.3
72.81
71.51
e9/l
0.10
43
219
144
943
1.85
7.39
3.8
3.4
0.34
0.47
e6/l
0.67
110
710
254
1992
1.84
7.05
6.7
4.3
6.97
6.71
mmol/l
1.24
242
1880
160
1097
1.80
6.97
3.9
3.5
25.26
36.02
e6/l
0.73
128
851
45
196
2.47
6.74
4.1
3.9
—
—
—
0
0
51
238
2.32
6.56
5.1
4.4
—
—
—
0
0
72
387
2.06
6.53
7.5
5.0
7.43
7.42
ph
0.07
42
227
71
383
2.05
6.37
7.5
4.9
0.68
1.48
mmol/l
0.81
63
320
10
9
11.37
5.82
1.1
1.0
—
—
—
0
0
152
1072
1.70
5.72
5.6
4.5
0.00
0.00
estimate
-0.00
54
351
178
1310
1.68
5.70
4.9
2.1
2.37
2.37
mmol/l
0.23
165
1151
31
122
2.68
5.70
1.9
1.6
1.56
0.87
ug/l
0.50
22
108
141
982
1.70
5.52
7.8
4.9
—
—
—
0
0
130
891
1.70
5.37
4.0
3.4
—
0.00
estimate
—
0
5
69
394
1.92
5.23
2.5
2.1
1.84
1.88
%
0.13
61
353
171
1269
1.64
5.15
4.8
4.2
106.98
125.21
e6/l
0.24
131
882
18
55
3.39
5.09
2.8
3.1
—
—
—
0
0
53
279
2.05
5.05
5.7
2.8
1.22
1.23
mmol/l
0.57
44
232
66
379
1.90
4.91
4.3
2.7
7.40
7.39
ph
0.76
44
230
81
503
1.78
4.68
3.0
2.4
20.01
20.31
%
0.06
68
464
37
175
2.24
4.62
4.3
3.4
7.42
7.42
ph
0.02
31
142
63
367
1.86
4.47
4.6
2.7
1.70
2.33
mmol/l
0.50
55
322
11
19
5.93
4.47
1.0
1.0
—
—
—
0
0
233
1908
1.58
4.37
5.5
4.6
0.00
0.00
estimate
-0.00
61
374
198
1565
1.56
4.32
5.0
4.0
6.47
6.35
ph
0.76
112
866
235
1934
1.57
4.26
5.6
4.6
28.45
0.00
estimate
0.49
66
393
85
550
1.70
4.23
3.0
2.3
2.21
2.39
g/l
1.67
73
505
56
321
1.87
4.18
2.9
2.4
3.24
5.40
ug/l
1.29
46
272
211
1701
1.55
4.15
7.0
5.4
1.66
1.84
e9/l
1.05
191
1478
213
1722
1.54
4.13
7.2
5.6
0.17
0.19
e9/l
1.27
188
1484
208
1673
1.54
4.13
7.1
5.4
0.04
0.04
e9/l
1.92
183
1421
111
777
1.61
4.05
3.2
2.7
5.75
7.30
e6/l
0.98
102
719
206
1663
1.53
3.95
7.1
5.4
0.56
0.58
e9/l
0.46
179
1412
23
96
2.49
3.80
3.1
3.1
24.10
25.73
mmol/l
0.99
23
96
179
1412
1.51
3.77
16.6
10.4
0.00
0.00
e9/l
0.14
156
1145
98
677
1.60
3.75
5.2
4.0
—
—
—
0
0
274
2368
1.57
3.74
5.2
4.4
—
0.00
—
0
5
47
265
1.88
3.69
3.9
3.8
1.47
0.53
%
0.80
17
43
35
179
2.05
3.62
8.3
5.3
24.67
25.70
mmol/l
0.71
35
179
87
591
1.61
3.55
3.0
2.4
10.77
11.93
umol/l
0.70
73
544
17
64
2.73
3.44
2.2
2.6
15.31
15.96
%
0.41
17
64
344
3186
1.91
3.22
28.7
15.3
28.77
21.26
mg/l
4.37
311
2606
15
55
2.80
3.19
2.1
2.8
88.19
89.55
%
0.21
15
55
112
1458
0.67
3.12
1.9
1.9
1.31
1.29
mmol/l
0.13
88
1227
47
280
1.78
3.11
1.7
1.4
—
—
—
0
0
44
257
1.81
3.11
4.1
3.9
0.07
0.03
%
0.23
14
35
41
236
1.83
3.04
1.5
1.4
—
—
—
0
0
49
300
1.73
2.96
2.7
1.5
63.74
67.33
g/l
1.99
42
269
139
1082
1.45
2.95
8.2
5.3
—
—
—
0
0
93
671
1.51
2.88
4.0
3.2
453.52
482.68
mosm/kgh2o
0.85
84
598
6
9
6.75
2.87
2.2
1.1
15.00
11.78
%
—
6
9
6
9
6.75
2.87
1.3
1.3
11.83
15.98
ug/l
—
6
9
35
196
1.87
2.83
4.8
2.5
25.47
25.50
mmol/l
0.02
35
188
43
258
1.75
2.79
4.1
3.7
0.93
0.45
%
0.64
14
47
5
6
8.42
2.75
3.0
4.0
0.56
0.59
mmol/l
—
5
6
16
66
2.49
2.74
3.4
2.5
60.00
60.49
%
0.05
16
66
139
1096
1.42
2.71
3.9
2.2
56.92
58.33
u/l
0.08
127
989
6
10
6.08
2.71
1.7
1.3
—
—
—
0
0
53
341
1.64
2.67
3.2
2.0
6.72
5.20
umol/l
0.60
47
287
14
55
2.61
2.64
3.3
2.7
4.09
4.49
e9/l
0.33
14
55
12
41
2.99
2.64
1.0
2.7
0.94
0.90
%
—
5
30
75
527
1.53
2.61
3.5
3.3
4.14
4.30
e6/l
0.03
38
249
99
739
1.46
2.57
1.8
1.6
1.19
1.22
mg/l
0.06
76
584
5
7
7.22
2.55
4.0
1.0
—
—
—
0
0
43
265
1.70
2.55
2.3
1.5
—
—
—
0
0
181
1520
1.37
2.35
8.0
5.6
0.58
0.70
%
2.31
162
1399
42
264
1.66
2.33
3.6
4.1
0.00
0.00
%
-0.00
12
35
181
1522
1.36
2.32
8.1
5.6
8.83
8.73
%
0.18
163
1409
181
1523
1.36
2.30
8.0
5.5
2.71
2.90
%
0.49
164
1410
41
259
1.65
2.24
4.3
2.4
121.88
127.53
g/l
0.82
41
248
50
333
1.58
2.21
3.9
1.8
375.50
372.38
nmol/l
0.04
42
300
5
11
4.59
1.94
1.6
1.3
—
—
—
0
0
16
78
2.10
1.94
1.6
1.8
—
—
—
0
0
180
1542
1.32
1.93
8.0
5.5
24.23
27.71
%
3.18
166
1447
58
413
1.48
1.91
1.7
1.4
—
—
—
0
0
20
107
1.92
1.90
4.7
3.0
7.40
7.41
ph
0.78
20
107
6
17
3.57
1.84
1.5
1.2
5.22
7.35
mmol/l
—
6
17
14
66
2.16
1.84
3.5
1.3
—
—
—
0
0
105
837
1.35
1.82
4.2
2.3
2.50
2.47
mmol/l
2.07
97
752
51
358
1.49
1.80
4.0
2.9
104.64
79.21
ng/l
0.70
36
310
8
29
2.80
1.80
2.8
1.2
—
—
—
0
0
176
1519
1.30
1.73
7.8
5.5
60.47
57.74
%
1.86
163
1436
13
62
2.14
1.67
5.2
3.5
8.28
8.17
kpa
0.09
13
62
13
62
2.14
1.67
5.2
3.5
5.12
5.26
kpa
0.34
13
62
6
19
3.19
1.66
2.2
1.3
—
—
—
0
0
6
19
3.19
1.66
1.8
1.7
—
—
—
0
0
342
3257
1.54
1.65
23.8
14.4
—
—
—
0
0
18
98
1.88
1.64
4.7
1.5
1.25
1.34
ratio
0.20
13
62
5
14
3.60
1.62
2.8
1.6
—
—
—
0
0
25
152
1.69
1.61
1.2
1.3
—
—
—
0
0
20
114
1.80
1.60
3.2
1.9
1.07
1.17
g/l
0.50
20
109
167
1449
1.27
1.52
6.0
4.5
0.00
0.04
estimate
1.56
48
300
7
27
2.62
1.52
1.7
1.2
54.99
41.00
u/l
—
7
21
5
129
0.38
1.51
1.2
1.7
—
—
—
0
0
312
3275
0.73
1.50
5.9
6.5
2.66
2.68
mmol/l
0.12
277
3008
80
632
1.34
1.46
1.5
1.3
2.11
2.46
g/l
1.09
40
360
298
3147
0.75
1.46
7.8
7.2
40.62
39.88
mmol/mol
0.58
275
2934
20
118
1.73
1.44
3.7
2.4
442.33
227.92
mg/l
—
9
26
6
22
2.75
1.44
1.0
1.1
—
—
—
0
0
350
3367
1.55
1.40
32.8
19.1
139.20
139.74
mmol/l
3.55
343
3289
28
184
1.56
1.36
11.7
5.6
23.91
24.72
mmol/l
0.67
28
179
350
3371
1.53
1.34
32.9
19.2
3.95
3.97
mmol/l
0.66
343
3285
117
985
1.27
1.34
2.7
2.5
3.16
2.96
mg/l
0.41
95
845
43
312
1.43
1.32
1.4
1.6
—
—
—
0
0
8
34
2.38
1.30
1.0
1.1
—
—
—
0
0
20
123
1.66
1.26
5.3
3.4
—
—
—
0
0
8
36
2.25
1.25
1.1
1.1
—
—
—
0
0
5
19
2.65
1.22
1.0
1.2
—
—
—
0
0
5
19
2.65
1.22
2.0
1.1
—
46.99
—
0
8
217
1975
1.23
1.21
3.7
3.0
59.71
42.01
u/l
1.55
201
1817
6
26
2.33
1.19
1.0
1.3
—
—
—
0
0
304
3181
0.77
1.16
5.0
5.5
1.54
1.59
mmol/l
1.53
266
2902
266
2819
0.81
1.07
5.6
4.9
15.32
15.04
pmol/l
1.03
245
2571
45
343
1.35
1.06
1.5
1.3
—
—
—
0
0
9
47
1.94
1.03
1.0
1.1
—
—
—
0
0
7
35
2.02
1.00
6.7
1.7
391.40
41.81
u/ml
—
7
35
9
161
0.55
1.00
1.2
1.4
—
—
—
0
0
141
1251
1.20
0.96
3.6
3.2
1744.95
1342.59
ng/l
0.57
118
1076
91
773
1.23
0.95
1.9
1.8
1154.16
1231.18
nmol/l
0.32
66
572
309
3211
0.79
0.95
5.2
5.6
4.65
4.71
mmol/l
0.45
281
2941
12
71
1.71
0.90
1.3
1.2
—
—
—
0
0
19
128
1.51
0.87
1.4
1.3
—
—
—
0
0
160
1446
1.19
0.87
5.3
4.2
28.86
91.97
ng/l
0.82
130
1075
6
30
2.02
0.87
1.2
1.7
13.33
24.58
ng/l
—
6
30
60
716
0.81
0.78
1.5
1.3
40.01
40.98
iu/ml
0.02
18
227
57
682
0.81
0.77
1.4
1.3
13.86
14.05
u/ml
0.00
19
250
6
34
1.78
0.76
1.0
1.1
—
—
—
0
0
94
1069
0.84
0.75
4.4
3.5
—
—
—
0
0
132
1187
1.17
0.75
1.9
1.8
19.56
21.33
nmol/l
0.64
113
996
5
24
2.10
0.75
2.0
2.0
—
—
—
0
0
5
24
2.10
0.75
1.0
1.5
—
—
—
0
0
351
3428
1.35
0.73
36.1
20.6
75.88
72.64
umol/l
0.97
344
3376
7
40
1.76
0.71
2.4
2.5
—
—
—
0
0
7
40
1.76
0.71
1.0
1.2
—
—
—
0
0
7
42
1.68
0.68
1.0
1.2
—
—
—
0
0
7
42
1.68
0.68
1.0
1.2
—
—
—
0
0
7
42
1.68
0.68
1.0
1.2
—
—
—
0
0
5
93
0.53
0.67
1.0
1.1
—
—
—
0
0
7
43
1.64
0.67
2.0
2.0
87.79
89.98
%
—
7
43
7
43
1.64
0.67
1.0
1.2
—
—
—
0
0
16
111
1.46
0.67
7.8
5.5
—
—
—
0
0
7
44
1.60
0.65
1.0
1.1
—
22.77
—
0
10
51
426
1.23
0.64
3.6
2.8
4.45
4.71
e9/l
0.21
40
356
12
79
1.54
0.63
1.2
1.1
—
136.00
—
0
5
306
3155
0.84
0.63
6.5
6.4
2.19
1.97
mu/l
1.56
281
2905
5
30
1.68
0.61
1.2
1.3
—
—
—
0
0
5
30
1.68
0.61
1.6
1.8
2.74
126.66
u/ml
—
5
30
14
97
1.46
0.60
1.4
1.2
1048.79
481.24
mg/l
0.51
14
91
132
1206
1.15
0.59
2.7
2.3
231.42
164.55
u/l
0.62
124
1141
95
854
1.15
0.54
1.9
1.7
417.98
8746836.83
pmol/l
0.50
77
686
317
3249
0.85
0.53
5.7
5.7
6.12
5.96
mmol/l
1.28
281
2958
101
914
1.14
0.52
6.2
4.6
1.02
1.02
kg/l
1.00
78
598
295
3038
0.87
0.51
4.4
4.6
1.36
1.26
mmol/l
1.51
260
2736
13
179
0.72
0.51
1.1
1.1
—
—
—
0
0
7
45
1.57
0.49
1.0
1.1
—
—
—
0
0
24
299
0.79
0.49
1.3
1.6
—
—
—
0
0
20
255
0.77
0.48
1.3
1.3
—
—
—
0
0
21
166
1.28
0.44
4.5
1.9
22.30
6.71
iu/ml
—
9
40
8
58
1.39
0.42
1.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
126.47
—
0
15
343
3371
1.19
0.41
17.2
10.9
23.67
22.15
u/l
0.59
333
3245
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
3.4
—
27.90
—
0
10
5
35
1.43
0.39
1.4
1.2
—
—
—
0
0
8
111
0.71
0.37
1.0
1.1
—
—
—
0
0
351
3460
1.21
0.37
42.6
23.8
37.96
39.12
%
3.78
344
3408
351
3460
1.21
0.37
41.7
23.5
30.13
30.16
pg
0.13
344
3409
351
3460
1.21
0.37
41.8
23.6
261.24
256.81
e9/l
0.57
343
3373
351
3460
1.21
0.37
41.9
23.6
6.94
6.66
e9/l
0.53
341
3353
351
3460
1.21
0.37
41.7
23.5
91.46
91.33
fl
0.20
344
3409
351
3460
1.21
0.37
41.8
23.6
4.24
4.35
e12/l
3.85
341
3356
351
3461
1.21
0.36
42.4
23.8
125.99
130.49
g/l
7.43
345
3410
33
284
1.18
0.34
1.2
1.1
—
—
—
0
0
6
45
1.34
0.34
2.0
3.1
—
—
—
0
0
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
7
52
1.35
0.31
1.7
1.2
—
—
—
0
0
39
344
1.15
0.31
6.0
4.0
7.39
7.35
ph
2.07
31
227
7
57
1.23
0.29
1.1
1.1
—
—
—
0
0
12
95
1.27
0.26
2.1
1.9
124.25
129.09
g/l
0.41
12
75
54
494
1.11
0.25
1.2
1.2
—
—
—
0
0
78
729
1.09
0.24
3.4
4.8
75.98
258.36
ng/l
1.19
64
602
20
232
0.85
0.23
1.9
2.5
—
—
—
0
0
5
38
1.32
0.23
3.4
2.6
—
—
—
0
0
21
182
1.16
0.22
1.2
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
172
1776
0.94
0.21
2.4
2.3
93.76
98.99
pmol/l
0.67
106
822
0
13
0.00
0.21
0.0
1.0
—
5.60
—
0
13
85
804
1.07
0.20
3.7
2.2
359.12
331.14
umol/l
1.13
73
681
9
111
0.81
0.20
1.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
58.50
—
0
14
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
6
51
1.18
0.19
1.0
1.2
—
—
—
0
0
7
60
1.17
0.18
1.6
1.2
—
—
—
0
0
181
1762
1.05
0.17
2.6
2.6
75.09
82.33
nmol/l
2.34
151
1557
40
432
0.92
0.17
1.4
2.0
193.76
152.57
ug/g
0.22
33
335
45
482
0.92
0.16
1.6
1.4
1004.44
658.36
titre
—
9
122
8
73
1.10
0.16
1.4
1.6
—
—
—
0
0
12
107
1.13
0.08
1.3
1.4
215.33
301.14
ug/g
—
6
63
129
1316
0.97
0.08
4.9
3.9
10.45
7.13
mg/mmol
0.27
87
759
7
68
1.03
0.08
4.4
1.8
39.31
55.81
%
—
7
68
157
1594
0.97
0.07
3.4
3.1
159.20
89.71
ug/l
2.90
143
1465
42
405
1.04
0.06
2.5
2.3
0.00
0.04
estimate
—
5
76
22
231
0.95
0.04
1.2
1.2
160.50
100.82
u/ml
—
6
95
13
139
0.93
0.03
1.2
1.5
—
—
—
0
0
80
813
0.98
0.03
1.3
1.3
0.75
1.40
u/ml
0.89
17
221
18
189
0.95
0.03
1.4
1.4
—
—
—
0
0
99
978
1.02
0.03
5.0
4.0
0.00
0.00
estimate
0.50
47
296
128
1292
0.99
0.02
3.9
3.3
38.54
31.62
mg/l
0.27
90
747
13
124
1.05
0.00
10.7
9.3
—
—
—
0
0
132
1319
1.00
0.00
3.7
3.2
5.86
5.99
mmol/l
0.14
113
1094
23
226
1.02
0.00
2.0
2.3
—
—
—
0
0
26
264
0.98
0.00
1.5
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1.85
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
1.7
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
5
50
1.00
-0.00
1.4
1.2
24.32
20.77
u/l
—
5
42
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
19.35
—
0
6
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
5
51
0.98
-0.00
2.0
5.2
223.40
363.82
umol/l
—
5
45

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_VULVA – Malignant neoplasm of vulva

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).